Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome [0.03%]
代谢综合征患者的适应性免疫与急性冠脉综合症后的冠脉疾病严重程度相关性研究
Maria C Izar,Henrique A Fonseca,Luiz F Pinheiro et al.
Maria C Izar et al.
Metabolic syndrome (MetS) is an inflammatory state associated with high coronary disease risk. Inflammation and adaptive immunity modulate atherosclerosis and plaque instability. We examined early changes in anti-oxidized low-density lipopr...
Alpha-glucosidase inhibitors 2012 - cardiovascular considerations and trial evaluation [0.03%]
2012年α-糖苷酶抑制剂与心血管考量及临床试验评估
Eberhard Standl,Oliver Schnell
Eberhard Standl
Alpha-glucosidase inhibitors have been available for clinical use for about 20 years. They have shown reasonably good efficacy comparable to other oral blood glucose lowering drugs and in some parts of the world are the most commonly prescr...
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin [0.03%]
糖尿病患者用阿司匹林一级和二级预防心血管疾病的效果
Oliver Schnell,Michael Erbach,Michael Hummel
Oliver Schnell
Diabetes is associated with an increased cardiovascular risk. The role for aspirin in diabetes is of high clinical interest. Guidelines recommend that primary prevention of cardiovascular disease (CVD) in diabetes with aspirin should be bas...
The diabetic patient has a higher benefit from infrapopliteal revascularization than the non-diabetic patient: a 10-year retrospective study [0.03%]
糖尿病患者胫动脉旁路术的获益高于非糖尿病患者——一项为期十年的研究
Alexander Oberhuber,Brigitte Benecke,Karl-Heinz Orend et al.
Alexander Oberhuber et al.
Objective: The objective of this article is to evaluate the limb salvage and patency rates after crural arterial revascularization, differences between graft material and co-morbidities. ...
GLP-1 receptor agonists: a clinical perspective on cardiovascular effects [0.03%]
GLP-1受体激动剂：心血管效应的临床分析
Dhanwantee Mundil,Alison Cameron-Vendrig,Mansoor Husain
Dhanwantee Mundil
The active incretin hormone glucagon-like peptide-1(7-36)amide (GLP-1) is a 30-amino acid peptide that exerts glucoregulatory and insulinotropic actions by functioning as an agonist for the GLP-1 receptor (GLP-1R). In addition to its anti-d...
Drugs for type 2 diabetes mellitus: the imperative for cardiovascular outcome assessment [0.03%]
2型糖尿病药物治疗的心血管结局评估不容忽视
M Odette Gore,Darren K McGuire
M Odette Gore
Kroekkiat Chinda,Siriporn Chattipakorn,Nipon Chattipakorn
Kroekkiat Chinda
Incretin is a gut derived peptide hormone secreted in the intestine after food ingestion, and is degraded rapidly after secretion by dipeptidyl peptidase (DPP)-4. Incretin-based therapy, such as glucagon-like peptide (GLP)-1 and the DPP-4 i...
Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus [0.03%]
骨保护素、瘦素和IL-6与2型糖尿病患者无症状心肌缺血的关系研究
Savas Guzel,Arzu Seven,Ali Kocaoglu et al.
Savas Guzel et al.
Background: Diabetic patients often exhibit severe, asymptomatic coronary artery disease (CAD). The relationship between osteoprotegerin (OPG), inflammatory markers and silent myocardial ischemia remains to be elucidated....
Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland [0.03%]
改良糖尿病联合会标准定义的代谢综合征与2型糖尿病风险：芬兰老年人长达9年的随访研究
Marika Salminen,Marikka Kuoppamäki,Tero Vahlberg et al.
Marika Salminen et al.
The aim was to analyse the relationship between metabolic syndrome and type 2 diabetes mellitus risk among the aged. This was a prospective population-based study, with a 9-year follow-up. All subjects of the municipality of Lieto in Finlan...
Atherogenic indices and prehypertension in obese and non-obese children [0.03%]
肥胖和非肥胖儿童代谢综合征指标与高血压前期的关系研究
Martha Rodríguez-Morán,Fernando Guerrero-Romero,Celia Aradillas-García et al.
Martha Rodríguez-Morán et al.
We evaluate the relationship between different lipoproteins and atherogenic indices with pre-hypertension in 297 obese and 942 non-obese children with Tanner stage 1 enrolled in a multicentre, community-based cross-sectional study. Height, ...
Multicenter Study
Diabetes & vascular disease research. 2013 Jan;10(1):17-24. DOI:10.1177/1479164112440713 2013